Range
6.28 - 6.65
Vol / Avg.
10.5K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
117.8M
Payout Ratio
-
Open
6.51
P/E
-
EPS
-0.19
Shares
18.8M
Outstanding
18.8M
Total Float
2.7M
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-12-10
REV
Q2 2021Est.ActualSurprise
EPS-1.000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

IN8bio Questions & Anwsers

Q

How do I buy IN8bio (INAB) stock?

A

You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are IN8bio's (INAB) competitors?

A

There are no as such competitors for IN8bio.

Q

What is the target price for IN8bio (INAB) stock?

A

The latest price target for IN8bio (NASDAQ: INAB) was reported by Mizuho on August 24, 2021. The analyst firm set a price target for 12.00 expecting INAB to rise to within 12 months (a possible 91.08% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for IN8bio (INAB)?

A

The stock price for IN8bio (NASDAQ: INAB) is $6.28 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does IN8bio (INAB) pay a dividend?

A

There are no upcoming dividends for IN8bio.

Q

When is IN8bio (NASDAQ:INAB) reporting earnings?

A

IN8bio’s $Q3 earnings are confirmed for after-market on $December 10, 2021.

Q

Is IN8bio (INAB) going to split?

A

There is no upcoming split for IN8bio.

Q

What sector and industry does IN8bio (INAB) operate in?

A

IN8bio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.